Amerikanische Gesellschaft für Hirudotherapie

Neuro-immune lessons from an annelid: The medicinal leech

Review published in Dev Comp Immunol (2016)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Narrative reviewAntimikrobielle ResistenzGenomik & ProteomikTasiemski A, Salzet M · Developmental and comparative immunology, 2016

Abstract

An important question that remains unanswered is how the vertebrate neuroimmune system can be both friend and foe to the damaged nervous tissue. Some of the difficulty in obtaining responses in mammals probably lies in the conflation in the central nervous system (CNS), of the innate and adaptive immune responses, which makes the vertebrate neuroimmune response quite complex and difficult to dissect. An alternative strategy for understanding the relation between neural immunity and neural repair is to study an animal devoid of adaptive immunity and whose CNS is well described and regeneration competent. The medicinal leech offers such opportunity. If the nerve cord of this annelid is crushed or partially cut, axons grow across the lesion and conduction of signals through the damaged region is restored within a few days, even when the nerve cord is removed from the animal and maintained in culture. When the mammalian spinal cord is injured, regeneration of normal connections is more or less successful and implies multiple events that still remain difficult to resolve. Interestingly, the regenerative process of the leech lesioned nerve cord is even more successful under septic than under sterile conditions suggesting that a controlled initiation of an infectious response may be a critical event for the regeneration of normal CNS functions in the leech. Here are reviewed and discussed data explaining how the leech nerve cord sensu stricto (i.e. excluding microglia and infiltrated blood cells) recognizes and responds to microbes and mechanical damages.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleReviewResearch Support, Non-U.S. Gov't
Indexed MeSH termsAnimalsAnnelidaAntimicrobial Cationic PeptidesCentral Nervous SystemHumansImmunity, InnateLeechesMammalsModels, AnimalNeuroimmunomodulationNeuronsReceptors, Pattern Recognition

Zusammenfassung

Review of medicinal leech CNS neuro-immune responses to microbes and damage, with regeneration enhanced under septic conditions, providing alternative model to mammalian adaptive immunity.

Warum dies für die Hirudotherapie relevant ist

This review examines the medicinal leech as a model organism for studying neuro-immune interactions, highlighting that the leech nerve cord can regenerate after crush or partial cut injury, with regeneration even enhanced under septic conditions. It discusses how the leech CNS recognizes and responds to microbes and mechanical damage, offering a simpler system than mammalian CNS to dissect relations between innate immunity and neural repair. For ASH's domain, this work is relevant because it positions the medicinal leech as a scientifically valuable organism whose innate immune and regenerative biology may indirectly inform understanding of hirudotherapy contexts. However, the article is a review focused on comparative neurobiology and innate immunity; it does not address leech therapy, salivary components, or clinical applications, so its relevance to hirudotherapy practice is indirect and conceptual rather than translational.

Zitation

Neuro-immune lessons from an annelid: The medicinal leech.

Tasiemski A, Salzet M · Developmental and comparative immunology, 2016

Verwandter klinischer Kontext

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.